Total Payments
$2,650
2024 Payments
$144.14
Companies
20
Transactions
129
Medicare Patients
1,480
Medicare Billing
$199,350

Payment Breakdown by Category

Food & Beverage$2,561 (96.6%)
Education$89.00 (3.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,561 128 96.6%
Education $89.00 1 3.4%

Top Paying Companies

Company Total Records Latest Year
Merck Sharp & Dohme LLC $414.72 16 $0 (2022)
Janssen Pharmaceuticals, Inc $411.30 16 $0 (2024)
Astellas Pharma US Inc $350.47 15 $0 (2021)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $228.28 8 $0 (2022)
Novartis Pharmaceuticals Corporation $209.69 13 $0 (2020)
PFIZER INC. $186.56 14 $0 (2022)
AstraZeneca Pharmaceuticals LP $181.13 8 $0 (2022)
Boehringer Ingelheim Pharmaceuticals, Inc. $157.46 10 $0 (2020)
E.R. Squibb & Sons, L.L.C. $92.46 7 $0 (2020)
Shionogi Inc $75.47 3 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $144.14 2 Janssen Pharmaceuticals, Inc ($123.77)
2023 $43.60 2 Janssen Pharmaceuticals, Inc ($43.60)
2022 $179.87 8 Shionogi Inc ($55.10)
2021 $241.08 8 Astellas Pharma US Inc ($154.86)
2020 $196.01 12 PFIZER INC. ($39.34)
2019 $757.90 39 Merck Sharp & Dohme Corporation ($177.54)
2018 $899.74 46 Merck Sharp & Dohme Corporation ($203.78)
2017 $187.29 12 SANOFI-AVENTIS U.S. LLC ($39.93)

All Payment Transactions

129 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
05/08/2024 Shionogi Inc Fetroja (Drug) Food and Beverage In-kind items and services $20.37 General
Category: Infections and Infectious Diseases
02/16/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $123.77 General
Category: Cardiovascular & Metabolism
04/25/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $25.59 General
Category: Cardiovascular & Metabolism
03/29/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $18.01 General
Category: Cardiovascular & Metabolism
07/26/2022 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $18.35 General
Category: Cardiovascular & Metabolism
07/11/2022 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $19.72 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
06/21/2022 Shionogi Inc Fetroja (Drug) Food and Beverage In-kind items and services $30.69 General
Category: Infections and Infectious Diseases
04/26/2022 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $23.34 General
Category: Cardiovascular and Metabolism
04/14/2022 Shionogi Inc Fetroja (Drug) Food and Beverage In-kind items and services $24.41 General
Category: Infections and Infectious Diseases
04/11/2022 Merck Sharp & Dohme LLC DIFICID (Drug), ZERBAXA, RECARBRIO Food and Beverage In-kind items and services $21.38 General
Category: INFECTIOUS DISEASE
04/04/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), RELISTOR Food and Beverage In-kind items and services $17.03 General
Category: Gastroenterology
02/04/2022 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $24.95 General
Category: Cardiovascular and Metabolism
07/27/2021 Astellas Pharma US Inc Education In-kind items and services $89.00 General
06/25/2021 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $30.74 General
Category: Cardiovascular & Metabolism
06/23/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug), XIFAXAN Food and Beverage In-kind items and services $14.40 General
Category: Gastroenterology
05/20/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug), XIFAXAN Food and Beverage In-kind items and services $19.73 General
Category: Gastroenterology
04/23/2021 Astellas Pharma US Inc CRESEMBA (Drug) Food and Beverage In-kind items and services $24.05 General
Category: HOSPITAL AND TRANSPLANT
04/13/2021 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $21.35 General
Category: Cardiovascular and Metabolism
03/17/2021 Astellas Pharma US Inc AMBISOME (Drug) Food and Beverage In-kind items and services $20.27 General
Category: HOSPITAL AND TRANSPLANT
03/01/2021 Astellas Pharma US Inc LEXISCAN (Drug) Food and Beverage In-kind items and services $21.54 General
Category: HOSPITAL AND TRANSPLANT
11/16/2020 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug), SPIRIVA RESPIMAT Food and Beverage In-kind items and services $19.04 General
Category: DIABETES
11/12/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $19.81 General
Category: Cardiovascular & Metabolism
04/02/2020 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), RELISTOR Food and Beverage In-kind items and services $21.57 General
Category: GASTROENTEROLOGY
03/10/2020 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $11.61 General
Category: CARDIOVASCULAR
02/28/2020 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $12.57 General
Category: CARDIOVASCULAR;METABOLIC DISEASE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 368 712 $172,244 $52,885
2022 7 414 769 $134,480 $53,385
2021 4 298 518 $70,310 $36,709
2020 4 400 760 $110,730 $56,370
Total Patients
1,480
Total Services
2,759
Medicare Billing
$199,350
Procedure Codes
21

All Medicare Procedures & Services

21 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 130 346 $64,422 $19,623 30.5%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 57 179 $47,915 $16,232 33.9%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 110 116 $31,912 $9,798 30.7%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 32 32 $16,559 $4,416 26.7%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 25 25 $8,806 $2,013 22.9%
99238 Hospital discharge day management, 30 minutes or less Facility 2023 14 14 $2,630 $804.08 30.6%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 172 400 $54,472 $21,697 39.8%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 81 203 $39,372 $16,200 41.1%
99239 Hospital discharge day management, more than 30 minutes Facility 2022 92 93 $20,939 $7,543 36.0%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 30 31 $11,385 $5,127 45.0%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 13 13 $3,179 $1,338 42.1%
99225 Follow-up observation care per day, typically 25 minutes Facility 2022 12 15 $2,718 $874.30 32.2%
99238 Hospital discharge day management, 30 minutes or less Facility 2022 14 14 $2,416 $605.30 25.1%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 172 360 $41,400 $21,741 52.5%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 60 92 $14,720 $8,068 54.8%
99239 Hospital discharge day management, more than 30 minutes Facility 2021 55 55 $10,725 $4,874 45.4%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 11 11 $3,465 $2,027 58.5%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 185 463 $53,245 $27,401 51.5%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 90 170 $27,200 $14,629 53.8%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 45 46 $14,490 $7,476 51.6%
99239 Hospital discharge day management, more than 30 minutes Facility 2020 80 81 $15,795 $6,865 43.5%

About Dr. Ifeoma Aduba, M.D

Dr. Ifeoma Aduba, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2014. The National Provider Identifier (NPI) number assigned to this provider is 1578983003.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ifeoma Aduba, M.D has received a total of $2,650 in payments from pharmaceutical and medical device companies, with $144.14 received in 2024. These payments were reported across 129 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,561).

As a Medicare-enrolled provider, Aduba has provided services to 1,480 Medicare beneficiaries, totaling 2,759 services with total Medicare billing of $199,350. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.

Practice Information

Products in Payments

  • XARELTO (Drug) $411.30
  • ZERBAXA (Drug) $280.75
  • ENTRESTO (Drug) $209.69
  • CRESEMBA (Drug) $201.26
  • XIFAXAN (Drug) $194.15
  • ELIQUIS (Drug) $178.27
  • LOKELMA (Drug) $157.20
  • DIFICID (Drug) $101.27
  • CHANTIX (Drug) $100.75
  • JARDIANCE (Drug) $94.87
  • Fetroja (Drug) $75.47
  • Kcentra (Biological) $74.19
  • Veltassa (Drug) $68.04
  • PRADAXA (Drug) $62.59
  • LANTUS (Drug) $39.93
  • RELISTOR (Drug) $34.13
  • Yupelri (Drug) $27.16
  • BRILINTA (Drug) $23.93
  • NOXAFIL (Drug) $22.23
  • JYNARQUE (Drug) $21.74

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Dallas